Abstract |
The CCL20 chemokine has potent antitumor activities through chemoattracting immature dentritic cells. But the maturation status of tumoral dentritic cells is important limiting factors in DC-based immunity. The endogenous availability of IL-15 was effective in inducing the dentritic cells maturation and IL-15 also shows tumor-specific antitumor activities. We constructed a CCL20/IL-15 bicistronic adenovirus (Ad-CCL20-IL-15) and confirmed its combined antitumor effect in vitro and in vivo. Intratumoral injection of Ad-CCL20-IL-15 into both CT-26 and B16F10 cells resulted in marked reduction of tumor growth in our model. Splenocytes treated by Ad-CCL20-IL-15 developed tumor-specific cytotoxic T cells and IFN-γ secretion could protect mice from rechallenging. This study suggests that CCL20/IL-15 can induce a strong antitumor immune response in tumor tissues and it is a suitable candidate for cancer immunotherapy.
|
Authors | Guang-yao Liu, Qiu-ying Jia, Zhi-jie Li, Ya-gang Li, Meng-meng Zhang, Ming-yuan Liu, Xue-lin Wang, Yang Li |
Journal | Immunobiology
(Immunobiology)
Vol. 219
Issue 6
Pg. 475-81
(Jun 2014)
ISSN: 1878-3279 [Electronic] Netherlands |
PMID | 24657179
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier GmbH. All rights reserved. |
Chemical References |
- CCL20 protein, mouse
- Chemokine CCL20
- Interleukin-15
- Interferon-gamma
|
Topics |
- Adenoviridae
(genetics)
- Animals
- Cell Line, Tumor
- Cell Movement
- Chemokine CCL20
(genetics)
- Dendritic Cells
(immunology)
- Gene Transfer Techniques
- Genetic Vectors
(genetics, therapeutic use)
- Humans
- Immunotherapy
- Interferon-gamma
(immunology, metabolism)
- Interleukin-15
(genetics)
- Killer Cells, Natural
(immunology)
- Mice
- Mice, Inbred BALB C
- Neoplasms
(immunology, therapy)
- T-Lymphocytes, Cytotoxic
(immunology)
|